Imagine a patient explaining that the hardest part of managing diabetes is fitting appointments around an unpredictable work schedule. The clinician listens, acknowledges the difficulty, and records it. The visit ends with the same appointment pattern and the same expectations.
This is an illustrative scenario, not a patient account. Nothing in it requires a clinician to be indifferent. It asks a different question: what choices did the service make available once the problem became clear?
Asking what matters creates an opportunity. Whether that opportunity changes care deserves separate attention.
A useful question still needs somewhere to go
A priority can be personally clear and operationally unresolved. “I want enough energy to care for my family” says something important about a person's life. It does not, by itself, determine which treatment changes are appropriate, which tradeoffs are acceptable, or who should arrange the next step.
For a service examining its own workflow, the useful unit of inquiry may be one concern followed through an entire decision. What did the team understand? What options could it offer? What did the patient choose? What happened after the visit?
Those questions keep the discussion grounded in delivery. They also leave room for an appropriate decision to keep a plan unchanged, provided the reasoning and tradeoffs have been considered together.
What a new trial adds
Published in October 2026, the QBSafe cluster randomized trial studied 143 adults with type 2 diabetes and 11 clinicians at one Connecticut federally qualified health center. Patients in the intervention group could select up to three of 14 conversation cards to help set the visit agenda. [1]
At six months, neither primary outcome clearly improved. The adjusted difference in illness intrusiveness was −3.9 points (95% CI, −10.4 to 2.6); the HbA1c difference was −0.2 percentage points (95% CI, −0.9 to 0.5). Clinician satisfaction and a medication-adherence measure favored the intervention, but these secondary findings should not replace the primary results.
With only 11 clinician clusters at one center, the findings leave uncertainty. They do not establish that asking about priorities has no value. Equally, the trial did not test and prove that adding a particular resource or staff role would solve the problem. That remains a question for further research.
Earlier evidence complicates a simple answer
The 2018 3D trial tested a broader patient-centered approach for people with multimorbidity. Across 33 UK practices and 1,546 patients, it found no improvement in its primary quality-of-life outcome: adjusted EQ-5D-5L difference 0.00 (95% CI, −0.02 to 0.02). It is an older, different intervention, not a direct comparison with QBSafe. [2]
Another foundational study, published in 2019, examined Patient Priorities Care in 366 older adults with multiple chronic conditions at two Connecticut practice sites. Priorities-aligned care was associated with a greater reduction in reported treatment burden and more medication discontinuation than usual care. [3]
That study was nonrandomized, with one intervention site and one comparison site. Differences between practices and patients could contribute to its findings despite statistical adjustment. Taken together, these studies support continued investigation; they do not establish one reliable pathway from a good conversation to better outcomes.
Follow the concern into the work
Our interpretation is that a team can learn something useful by tracing the response to a concern, even before it launches a larger improvement program. The following questions are prompts for local inquiry, not a validated assessment or an evidence-proven intervention.
- What decision could this priority change? Translate the concern into a choice that can be discussed. If it falls outside the current visit's scope, explain that boundary and identify whether another route exists.
- Who can carry the next step? A referral, benefits inquiry, scheduling request, or clinical review needs an owner. Examine whether responsibility is explicit and whether the person assigned has the capacity to act.
- How will the patient know what happened? Consider how an unresolved request comes back to the patient. A declined option or unavailable resource still requires a clear response; silence leaves the original concern open.
In the opening scenario, the investigation could begin with the scheduling process. Does it offer any flexibility? Can the clinician request a different arrangement? Who checks whether it worked? The answer may reveal a constraint the organization can address—or a limit that should be explained honestly.
Measure the response as well as the invitation
A local evaluation could distinguish whether priorities were discussed, whether a decision followed, and whether the patient found the resulting plan more workable. These are proposed process questions. They should accompany, rather than substitute for, outcomes appropriate to the intervention and its intended purpose.
A documented priority is evidence that something was recorded. A completed referral is evidence that a step occurred. Neither alone establishes that treatment became less burdensome or health improved. The measurement should follow the claim the service hopes to make.
The next time a team introduces a question about what matters, it could test the response pathway alongside the question itself. Follow one concern beyond the encounter. Find the point where someone can make a decision, provide a resource, or explain a limit. That is where an invitation to speak can begin to change the experience of care.
Educational commentary based on selected primary studies, not original research, a systematic review, or individualized medical advice. QBSafe full text and the published abstracts of the 3D and Patient Priorities Care studies were reviewed. The latter two are foundational context, not a current comprehensive evidence review. Sources checked October 23, 2026.
Sources & further reading
- Lipska KJ, Branda ME, Camp AW, et al. A Conversation Tool to Enhance Care for People With Type 2 Diabetes: The QBSafe Cluster Randomized Clinical Trial. JAMA Network Open. 2026;9(10):e2639032. doi:10.1001/jamanetworkopen.2026.39032.
- Salisbury C, Man MS, Bower P, et al. Management of multimorbidity using a patient-centred care model: a pragmatic cluster-randomised trial of the 3D approach. The Lancet. 2018;392(10141):41–50. doi:10.1016/S0140-6736(18)31308-4.
- Tinetti ME, Naik AD, Dindo L, et al. Association of Patient Priorities-Aligned Decision-Making With Patient Outcomes and Ambulatory Health Care Burden Among Older Adults With Multiple Chronic Conditions: A Nonrandomized Clinical Trial. JAMA Internal Medicine. 2019;179(12):1688–1697. doi:10.1001/jamainternmed.2019.4235.